Oct.26.2022, Auckland ------ ObvioHealth, a global Virtual Research Organization (VRO) pioneering end-to-end decentralized clinical trials (DCT), is collaborating with Oracle in Asia Pacific to help get breakthrough therapies to market faster through more efficient integration of diverse data sets. The alliance will enable the rapid collection, integration and analysis of multi-source data collected from sites, patients, devices and labs.
ObvioHealth is a Virtual Research Organization (VRO) leading the long overdue digitization of health innovation. We launched in 2017, leveraging technological innovation to tackle the inefficiencies in the trial process. But we knew then and now, that success would come from the fusion of experienced clinical researchers and pioneering health technologists. This is our winning prescription for seamless clinical trials.
A preferred Oracle provider in Asia Pacific, ObvioHealth is one of the first DCT players to conduct fully virtual studies in the region. In addition to its headquarters in New York, the company has offices in Singapore, Australia and Europe. The VRO is also partnered with Novotech, the leading Asia-Pacific biotech specialist CRO.
For more information about ObvioHealth, visit www.obviohealth.com